Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
OSUR
#2938
OraSure Technologies Inc
3.1
5
+1.94%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+1.94%
Monthly Change
+16.24%
6 month change
-5.69%
Cambio anual
-6.80%
Cierres anteriores
3.0
9
Open
3.1
5
Bid
Ask
Low
3.1
5
High
3.1
5
Volumen
50
Markets
Acciones
Atención Sanitaria
OSUR
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Cash from operating activities
12.68 M
109 K
-19.73 M
-10.22 M
-10.07 M
-39.92 M
Cash from investing activities
7.33 M
-5.49 M
370 K
-1.94 M
-821 K
-7.88 M
Cash from financing activities
-726 K
-111 K
-953 K
-5.8 M
-5.08 M
-11.94 M
Free cash flow
12.54 M
-347 K
-20.15 M
-12.16 M
-10.99 M
-43.65 M
OraSure Technologies Inc
OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test.
Noticias
OraSure Technologies, Inc. (OSUR) Q4 2025 Earnings Call Transcript
【決算速報】オラシュア・テクノロジーズ、売上高は予想を下回り、利益は予想と一致する結果に
OraSure earnings matched, revenue fell short of estimates
OraSure’s HIV self-test receives Health Canada license
Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates
アルタイ・キャピタル、オラシュア・テクノロジーズの取締役会に2名を指名
Altai Capital nominates two directors for OraSure Technologies board
アルタイ・キャピタル、OraSure取締役会に懸念を表明し2名の取締役を指名
Altai Capital nominates two directors to OraSure board amid concerns
OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device
OraSure submits FDA applications for rapid STI test and collection device
NeoGenomics、診断業界のベテラン Jack Kenny を取締役に任命